Lynbrook (United States)

Type: City
Name: Lynbrook (United States)
Country: United States
Latitude: 40.66
Longitude: -73.669998
population: 19,626
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Bethpage Federal Credit Union Commits To Long Island Young Professionals

- Sep. 12, 2014 - BETHPAGE, N.Y. -- Bethpage Federal Credit Union announces its partnership with The LIincs Organization, an emerging professional development association of young professionals on Long Island. As Founding Corporate Sponsor, Bethpage will ... [Published Prlog - Sep 12 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

LOCKHEED MARTIN : Patent Issued for Radio Frequency Power Transmission System

By a News Reporter-Staff News Editor at Defense & Aerospace Week -- According to news reporting originating from Alexandria, Virginia , by VerticalNews journalists, a patent by the inventors Winfield , Donald ( Camillus, NY ); Smigel, John R. ( Liverpool, ... [Published 4 Traders - Sep 04 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 2 reports

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

PR NewswireLYNBROOK, N.Y., Sept. 2, 2014LYNBROOK, N.Y. , Sept. 2, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX ® in the U.S. and ... [Published Reuters - Sep 02 2014]
First reported Aug 21 2014 - Updated Aug 22 2014 - 2 reports

BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite

LYNBROOK, N.Y."These positive results are very encouraging, particularly because both patients and physicians saw a statistically significant improvement in the appearance of cellulite after CCH treatment," commented Thomas L. WegmanThe Phase 2a study ... [Published Bio-Medicine - Aug 21 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

U.S. Patents Awarded to Inventors in New Jersey (Aug. 11)

Targeted News ServiceTargeted News Service Targeted News ServiceALEXANDRIA, Va., Aug. 11 -- The following federal patents were awarded to inventors in New Jersey.***International Business Machines Assigned Patent for Method for Enhancing Search and Browsing ... [Published Insurance News Net - Aug 11 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 2 reports

BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

LYNBROOK, N.Y., Aug. 11, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published TickerTech.com - Aug 11 2014]
First reported Aug 10 2014 - Updated Aug 10 2014 - 1 reports

Chessboard made from actual wood from the ocean liner Titanic sells for $16,385 at Philip

- A chessboard made from actual wood retrieved from the wreckage of the legendary ocean liner RMS Titanic sold for $16,385 at an auction held July 23 by Philip Weiss Auctions in Lynbrook, N.Y.LYNBROOK, N.Y. – A chessboard made from actual wood retrieved ... [Published PR inside - Aug 10 2014]
First reported Aug 09 2014 - Updated Aug 09 2014 - 1 reports

US Federal Business Opportunity: Department of the Army: Impervious Surface Evaluation

Agency: Department of the ArmyOffice: National Guard Bureau Location: 175th MSG/MSCDate you need to respond by: 20-August-2014Solicitation Number: W912K6-14-T-2035 Naics code: 541620 Management, Scientific, and Technical Consulting ServicesDescripti ... [Published ITbriefing - Aug 09 2014]
First reported Aug 08 2014 - Updated Aug 09 2014 - 3 reports

BioSpecifics Technologies Corp. Announces Initiation of Phase 2 Clinical Study of CCH for Treatment of Lipoma

LYNBROOK, N.Y."Our initiation of this Phase 2 placebo-controlled clinical trial of CCH in patients with lipoma represents another important development milestone for BioSpecifics as we further advance our pipeline and continue to uncover the vast potential ... [Published Bio-Medicine - Aug 08 2014]
First reported Aug 04 2014 - Updated Aug 05 2014 - 1 reports

BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014

LYNBROOK, N.Y., Aug. 4, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Health - Aug 04 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

BioSpecifics Technologies Corp. to Be Added to Russell 3000® Index

LYNBROOK, N.Y., June 27, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced that effective ... [Published PR Newswire: Health - Jun 27 2014]
First reported Jun 25 2014 - Updated Jun 26 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Filing by Sobi for EU Approval of XIAPEX for Peyronies Disease

LYNBROOK, N.Y., June 25, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced today that ... [Published PR Newswire: Health - Jun 25 2014]

Quotes

...addition to obtaining background information on this patent, VerticalNews editors also obtained the inventors' summary information for this patent: "In one embodiment of the present invention, a wireless energy transmission and storage system is provided. The system includes a first microwave transmission source and a second lightwave transmission source. The output of the first and second sources are received by a hybrid array arranged on an asset and configured to convert the received microwaves and lightwaves into direct current. An energy storage device is operatively connected to the hybrid array and configured to store the power delivered therefrom. A controller is provided and configured to control the supply of power from the hybrid array to the energy storage device."
"These positive results are very encouraging, particularly because both patients and physicians saw a statistically significant improvement in the appearance of cellulite after CCH treatment" commented Thomas L Wegman
...a statistically significant improvement in the appearance of cellulite after CCH treatment," commented Thomas L Wegman , President of BioSpecifics. "The market for cellulite treatment is large, which makes these data very exciting for the prospective commercial success of CCH in this indication. The results also position CCH as a potential treatment for other aesthetic needs, so we are eager to see continued progress by Auxilium in initiating a subsequent Phase 2b trial of CCH in cellulite in the second quarter of 2015."
"With the financial benefit realized from this commercial success, we maintain the ability to progress our proprietary pipeline. We were very excited to report last week the initiation of our Phase 2 clinical trial of CCH in human patients with lipoma. The data we reported in January were very promising and we hope to duplicate these positive results and progress this indication towards commercialization. We also submitted the final study report to Auxilium for CCH in canine lipoma, to which we will await their decision on whether to in-license this indication, making it the fifth indication within our development agreement."

More Content

All (27) | News (13) | Reports (0) | Blogs (14) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Bethpage Federal Credit Union Commits To Long I... [Published Prlog - Sep 12 2014]
LOCKHEED MARTIN : Patent Issued for Radio Frequ... [Published 4 Traders - Sep 04 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published Reuters - Sep 02 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: Health - Sep 02 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published Bio-Medicine - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published TheStreet.com - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published Stock Nod - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published Reliance Trust - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published PR Newswire: Health - Aug 21 2014]
BioSpecifics Technologies Corp. Reports Second ... [Published TickerTech.com - Aug 11 2014]
BioSpecifics Technologies Corp. Reports Second ... [Published PR Newswire: Financial Services - Aug 11 2014]
U.S. Patents Awarded to Inventors in New Jersey... [Published Insurance News Net - Aug 11 2014]
Chessboard made from actual wood from the ocean... [Published PR inside - Aug 10 2014]
US Federal Business Opportunity: Department of ... [Published ITbriefing - Aug 09 2014]
BioSpecifics Technologies Corp. Announces Initi... [Published Bio-Medicine - Aug 08 2014]
BioSpecifics Technologies Corp. Announces Initi... [Published TickerTech.com - Aug 08 2014]
BioSpecifics Technologies Corp. Announces Initi... [Published PR Newswire: Health - Aug 08 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Aug 04 2014]
BioSpecifics Technologies Corp. to Be Added to ... [Published PR Newswire: Health - Jun 27 2014]
BioSpecifics Technologies Corp. Announces Filin... [Published PR Newswire: Health - Jun 25 2014]
BioSpecifics Announces New Analyses of XIAFLEX ... [Published PR Newswire: Health - May 19 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - May 12 2014]
BioSpecifics Technologies Corp. Reports First Q... [Published PR Newswire: Health - May 08 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - May 01 2014]
BioSpecifics Technologies Corp. to Present at t... [Published PR Newswire: Health - Apr 02 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Feb 27 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - Feb 19 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: Health - Sep 02 2014]
LYNBROOK, N.Y., Sept. 2, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced today that ...
BioSpecifics Technologies Corp. Announces Posit... [Published PR Newswire: Health - Aug 21 2014]
LYNBROOK, N.Y., Aug. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. Reports Second ... [Published PR Newswire: Financial Services - Aug 11 2014]
LYNBROOK, N.Y., Aug. 11, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. Announces Initi... [Published PR Newswire: Health - Aug 08 2014]
LYNBROOK, N.Y., Aug. 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Aug 04 2014]
LYNBROOK, N.Y., Aug. 4, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.